as on February 27, 2026 at 9:31 pm IST
Day's Low
0.63%
Downside
52 Week's Low
52 Week's High
17.47%
Downside
21.93%
Upside
as on February 27, 2026 at 4:01 pm IST
Market Cap
₹321.00 Cr
Return on Equity (ROE)
22.04
PE Ratio (TTM)
16.01
Return on capital employed (ROCE)
27.61
Industry PE ratio
42.7
Beta (LTM)
-0.1
P/B Ratio
4.5
Dividend Yield
0PEG Ratio
1.93
Quarterly Earnings Growth YOY
81.64
EPS (TTM)
9.13
Sector
Pharmaceuticals
Book Value
56.05
Technical Analysis
Bearish
View Technical Analysis
as on February 27, 2026 at 4:01 pm IST
Trident Lifeline in the last 5 years
Lowest (6.24x)
January 9, 2023
Today (16.01x)
February 27, 2026
Industry (42.70x)
February 27, 2026
Highest (57.39x)
September 5, 2024
Today’s Price to Earnings Ratio: 16.01x
Compare market cap, revenue, PE, and other key metrics of Trident Lifeline with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 321.00 | 29.75% | 0.74 | 10 | 86 | |
| NA | 79.00 | 41.84% | 0.70 | 1 | 45 | |
| NA | 273.07 | 34.3% | 0.58 | 18 | 137 | |
| BUY | 15,437.18 | -4.25% | 0.57 | -18 | 1,444 | |
| BUY | 20,753.55 | -3.57% | 0.69 | 91 | 9,151 |
Search interest for Trident Lifeline Ltd Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Trident Lifeline.
Trident Lifeline Ltd’s net profit jumped 54.12% since last year same period to ₹4.30Cr in the Q3 2025-2026. On a quarterly growth basis, Trident Lifeline Ltd has generated -13.13% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
![]()
Promoters have increased holdings from 63.11% to 64.11% in Dec 2025 quarter
Price Rise
![]()
In the last 7 days, Trident Lifeline stock has moved up by 5.9%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 196.8% return, outperforming this stock by 121.8%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 47.0% return, outperforming this stock by 27.4%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 28.78% to 28.50% in Dec 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 7.71% to 7.04% in Dec 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 33.01 Cr → 30.34 Cr (in ₹), with an average decrease of 8.1% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 4.95 Cr → 4.3 Cr (in ₹), with an average decrease of 13.1% per quarter
| Organisation | Trident Lifeline Ltd |
| Headquarters | Surat |
| Industry | Pharmaceuticals |
| CEO | Hardik J Desai |
| E-voting on shares | Click here to vote |
Trident Lifeline share price today stands at ₹269 as on at the close of the market. Trident Lifeline share today touched a day high of ₹269 and a low of ₹267.3.
Trident Lifeline touched a 52 week high of ₹328 and a 52 week low of ₹222. Trident Lifeline share price today i.e. is closed at ₹269, which is -17.99% down from its 52 week high and 21.17% up from its 52 week low.
Trident Lifeline market capitalisation is ₹321.00 Cr as on .
To buy Trident Lifeline shares, you need to follow these steps:
Trident Lifeline trading volume is 1,800.00 as on . This means that 1,800.00 shares of Trident Lifeline were bought and sold on the stock market during today's trading session.